ABBV-181

ABBV-181 is an Immuno-Oncology therapy under development for the treatment of solid tumors.

Type of Molecule

Biologic

Target

n/a

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Solid Tumors n/a
Phase 1